← k3vl4r
Log inGet started →

SNY (Sanofi) Price Forecast

AI-generated price forecast for Sanofi (SNY) across 1-hour, 4-hour, daily and weekly horizons — updated continuously, with a public accuracy track record.

The desk streams live daily· see the schedule →

As of August 2026: K3vl4r's AI model currently reads SNY as 1/1 bullish across its horizons (1 of 1 timeframes pointing up), with a last price of 44.42. See our public, auditable track record →

📈 Daily Top Picks beating the S&P 500 since launch→✓ Public, verifiable track record Live system status💎 Get the full AI report · pay with XRP

Last price

44.42

AI outlook

1/1 bullish

Timeframes up

1 / 1

Share𝕏PostTelegram

SNY forecast by horizon

HorizonDirectionProjected move (end of horizon)Bullish prob.
1-hour———
4-hour~7 weeks out———
Daily~4 months out▲ Up+1.62%—
Weekly~1.9 years out———

Congressional trades in SNY

Public STOCK Act disclosures · amounts are ranges, reported up to ~45 days after the trade.

MemberActionDateAmount
Alan Armstrong▲ Buy2026-03-30$15001–50000

Track what Congress is trading across the whole market in the app — get started free.

Latest SNY news

From the market-news feed the forecasts are read against.

  • Nektar: Maintaining 'Strong Buy' Rating Due To REZPEG Catalyst, Another Coming · SeekingAlpha · Aug 14
  • Sanofi: Information concerning the total number of voting rights and shares - July 2026 · ldr:biopharmawatch.com · Aug 13
  • [Latest] Global Whey Protein Market Size/Share Worth USD 26.04 Billion by 2034 at a 7.56% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth, Growth Rate, Value) · Yahoo · Aug 12
  • InduPro Closes $77 Million Series B Financing and Doses First Patient in Phase 1 Study of Lead Oncology Program IDP-001 · Yahoo · Aug 12
  • A Profitable Rare-Disease Prize: Who Might Snap Up BioCryst? · Yahoo · Aug 11

🔒

See the full SNY forecast

Interactive forecast chart, price targets, and Monte-Carlo confidence bands — plus the daily AI Top Picks book. Free to start, no card required.

Create a free account →

Already have one? Log in

SNY forecast — frequently asked

Will SNY go up?

K3vl4r's AI model currently reads SNY as 1/1 bullish — 1 of 1 forecast horizons point up, so the overall read is leaning to the upside. This is a model-generated forecast for information only — not investment advice, and forecasts may be inaccurate.

What is the SNY price prediction for 2026?

K3vl4r's model projects SNY toward $44.34 over the next ~4 months, a +0.0% move from $44.33. Projections update continuously as new data arrives and are inherently uncertain. This is a model-generated forecast for information only — not investment advice, and forecasts may be inaccurate.

Part of Biotech & Pharma forecasts — browse the full sector.

More AI forecasts

BMYTEVAPFEPCRXAZNGSKPRGOLLYJNJNVOABBVMRKRPRXVTRS

Will SNY reach…?

Will SNY reach $50.00?Will SNY reach $100.00?Will SNY reach $200.00?Will SNY reach $250.00?

Or see the full SNY price prediction (2027–2040), or the forecast for today, tomorrow and this week.

Compare SNY

SNY vs BMYSNY vs TEVASNY vs PFESNY vs PCRXSNY vs AZNSNY vs GSK

Curious how this is generated? Read how K3vl4r forecasts — the model, the confidence bands, and what we deliberately do not claim.

K3vl4r publishes a public, auditable track record of its Daily Top Picks — see the live results.

Forecasts are model-generated estimates for informational purposes only and are not financial advice. Markets are risky; past accuracy does not guarantee future results. See our Risk Disclosure.

StreamWatch on Kick·Watch on YouTube
k3vl4rTop PicksTrack recordChart indicatorsToday's outlookStream scheduleBiggest moversMarket heatmapForecasts by sectorAI reportsMarket videosCompareMethodologyBest AI toolsAboutFAQ◈ KVLHow KVL worksTokenomicsPricingX (Twitter)YouTube — daily showsTikTokTwitch — live forecastingDiscord community

Join the community on Discord and catch the desk stream live on Kick or YouTube. Create a free account →

Forecasts are AI-generated; written analysis is AI-assisted and human-reviewed. Informational only, not financial advice. See Terms, Risk Disclosure, Privacy · Methodology · Status.